Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01024933 · ClinicalTrials.gov registry record · NA

Trial Using Motivational Interviewing Positive Affect and Self-Affirmation in Hypertension (TRIUMPH)

A NA study, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
238
Enrollment target

NCT01024933: Completed NA study, sponsored by Weill Medical College of Cornell University.

NCT01024933 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 238 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01024933, a NA study, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
238 participants
Enrollment target

Study Summary

The primary aim of this study is to evaluate whether an intervention that combines positive affect and self-affirmation with motivational interviewing (TRIUMPH) improves blood pressure control compared to an educational/behavioral contract intervention at 12 months. We hypothesize that a greater proportion of participants in the experimental arm of TRIUMPH will have adequate blood pressure control as defined by Seventh Joint National Committee on Detection, Evaluation and Treatment of Hypertension (JNC-7.)

Interventions

  • BEHAVIORAL Positive Affect/Self-Affirmation/Motivational Interviewing
  • BEHAVIORAL Educational and Behavioral

Trial Details

FieldValue
Enrollment Target 238 participants
Start Date 2010-01
Est. Completion 2014-04
Phase NA

What the finished NCT01024933 record still lists

NCT01024933 is an interventional study that assigns participants to a tested intervention. The registered 238 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).

The record links to 0 conditions, and to 2 interventions - of which Positive Affect/Self-Affirmation/Motivational Interviewing is the first listed.

NCT01024933 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01024933 about?

NCT01024933 is a clinical study titled "Trial Using Motivational Interviewing Positive Affect and Self-Affirmation in Hypertension (TRIUMPH)". The primary aim of this study is to evaluate whether an intervention that combines positive affect and self-affirmation with motivational interviewing (TRIUMPH) improves blood pressure control compared to an educational/behavioral contract intervention at 12 months. We hypothesize that a greater pro...

What is the current status of trial NCT01024933?

This trial is currently completed. It is a NA study. The enrollment target is 238 participants. The study started on 2010-01. Estimated completion is 2014-04.

What interventions are being tested in trial NCT01024933?

The interventions under investigation include: Positive Affect/Self-Affirmation/Motivational Interviewing (BEHAVIORAL), Educational and Behavioral (BEHAVIORAL).

Who is sponsoring clinical trial NCT01024933?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01024933's enrollment target sits among peer trials

238 459th of 2000 higher than 1,540 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05012072 · 238 participants · NA

    Reducing Pregnancy Risks: The Mastery Lifestyle Intervention

  • NCT05400252 · 238 participants · NA

    Whole Health in VA Mental Health: Omnis Salutis

  • NCT06380517 · 238 participants · Phase 3

    Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

  • NCT06452797 · 238 participants · NA

    Prognostic Estimates Among ICU Clinicians

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01024933, the US trial registry maintained by the National Library of Medicine. NCT01024933 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.